Clal Biotechnology reported ILS-5438000 in EBIT for its fiscal quarter ending in December of 2022.


Ebit Change Date
Clal Biotechnology ILS -5438000 3.76M Dec/2022
Compugen USD -8429000 946K Jun/2025
Life Technologies USD -367334 15.45M Jun/2025
RedHill Biopharma USD 2.69M 47.97M Jun/2023